| Joseph Jordan Simon, DO | |
|
3623 Latrobe Dr Ste 216, Charlotte, NC 28211-2117 | |
| (704) 332-1291 | |
| (704) 926-1832 |
| Full Name | Joseph Jordan Simon |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 15 Years |
| Location | 3623 Latrobe Dr Ste 216, Charlotte, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407198484 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Novant Health Huntersville Medical Center | Huntersville, NC | Hospital |
| Novant Health Matthews Medical Center | Matthews, NC | Hospital |
| Novant Health Presbyterian Medical Center | Charlotte, NC | Hospital |
| Lake Norman Regional Medical Center | Mooresville, NC | Hospital |
| Novant Health Mint Hill Medical Center | Charlotte, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beaumont Medical Group Hospital Based Services | 3072875889 | 457 |
| Mecklenburg Radiology Associates Pa | 6800789587 | 77 |
News Archive
Barr Pharmaceuticals has announced that its subsidiary, Duramed Pharmaceuticals has submitted a formal response in support of its Supplemental New Drug Application (sNDA) for an Over-the-Counter (OTC) Plan B(R) emergency contraceptive product.
Mount Sinai School of Medicine researchers presented 86 abstracts and plenary sessions at the American College of Cardiology's (ACC) 61st Annual Scientific Session, including ground-breaking research on aggressive statin therapy, the prevalence of unrecognized cardiovascular disease symptoms in women, and morbidity associated with non-adherence to medication after stent implantation. The meeting took place March 23-27, 2012 in Chicago.
Europe should take all possible measures to enhance the existing collaboration between paediatric oncologists, both in the treatment and research of childhood cancers.
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it will be presenting detailed results from its recently completed Phase 2a FDA trial on ORMD-0801, its orally ingestible insulin capsule at the 2014 GTC Diabetes Summit taking place from April 23-25, 2014, in Boston, Massachusetts, USA.
TSO3 Inc., an innovator in low temperature sterilization technology for medical devices in healthcare settings, through the use of ozone (a cost effective, safe and eco-friendly method) today announced that it has filed a patent application in the United States seeking protection in that market as well as preserving rights in many other countries of recent innovations made to its sterilization systems, which enable both significantly faster and gentler cycles.
› Verified 7 days ago
| Entity Name | Beaumont Medical Group Hospital Based Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427567858 PECOS PAC ID: 3072875889 Enrollment ID: O20180314001796 |
News Archive
Barr Pharmaceuticals has announced that its subsidiary, Duramed Pharmaceuticals has submitted a formal response in support of its Supplemental New Drug Application (sNDA) for an Over-the-Counter (OTC) Plan B(R) emergency contraceptive product.
Mount Sinai School of Medicine researchers presented 86 abstracts and plenary sessions at the American College of Cardiology's (ACC) 61st Annual Scientific Session, including ground-breaking research on aggressive statin therapy, the prevalence of unrecognized cardiovascular disease symptoms in women, and morbidity associated with non-adherence to medication after stent implantation. The meeting took place March 23-27, 2012 in Chicago.
Europe should take all possible measures to enhance the existing collaboration between paediatric oncologists, both in the treatment and research of childhood cancers.
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it will be presenting detailed results from its recently completed Phase 2a FDA trial on ORMD-0801, its orally ingestible insulin capsule at the 2014 GTC Diabetes Summit taking place from April 23-25, 2014, in Boston, Massachusetts, USA.
TSO3 Inc., an innovator in low temperature sterilization technology for medical devices in healthcare settings, through the use of ozone (a cost effective, safe and eco-friendly method) today announced that it has filed a patent application in the United States seeking protection in that market as well as preserving rights in many other countries of recent innovations made to its sterilization systems, which enable both significantly faster and gentler cycles.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Jordan Simon, DO Po Box 221249, Charlotte, NC 28222-1249 Ph: (704) 332-1291 | Joseph Jordan Simon, DO 3623 Latrobe Dr Ste 216, Charlotte, NC 28211-2117 Ph: (704) 332-1291 |
News Archive
Barr Pharmaceuticals has announced that its subsidiary, Duramed Pharmaceuticals has submitted a formal response in support of its Supplemental New Drug Application (sNDA) for an Over-the-Counter (OTC) Plan B(R) emergency contraceptive product.
Mount Sinai School of Medicine researchers presented 86 abstracts and plenary sessions at the American College of Cardiology's (ACC) 61st Annual Scientific Session, including ground-breaking research on aggressive statin therapy, the prevalence of unrecognized cardiovascular disease symptoms in women, and morbidity associated with non-adherence to medication after stent implantation. The meeting took place March 23-27, 2012 in Chicago.
Europe should take all possible measures to enhance the existing collaboration between paediatric oncologists, both in the treatment and research of childhood cancers.
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it will be presenting detailed results from its recently completed Phase 2a FDA trial on ORMD-0801, its orally ingestible insulin capsule at the 2014 GTC Diabetes Summit taking place from April 23-25, 2014, in Boston, Massachusetts, USA.
TSO3 Inc., an innovator in low temperature sterilization technology for medical devices in healthcare settings, through the use of ozone (a cost effective, safe and eco-friendly method) today announced that it has filed a patent application in the United States seeking protection in that market as well as preserving rights in many other countries of recent innovations made to its sterilization systems, which enable both significantly faster and gentler cycles.
› Verified 7 days ago
Whitney Feltus, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3623 Latrobe Dr Ste 216, Charlotte, NC 28211 Phone: 980-208-1704 Fax: 704-926-1832 | |
Edward Barnwell Black, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1705 East Blvd, Charlotte, NC 28203 Phone: 704-909-5960 Fax: 704-770-0501 | |
Thaddeus Drexel Houston, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1701 East Blvd, Charlotte, NC 28203 Phone: 704-334-7800 Fax: 704-414-7512 | |
Matthew James Locker, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3623 Latrobe Dr Ste 216, Charlotte, NC 28211 Phone: 704-332-1291 Fax: 704-926-1832 | |
Kelli A. Reardon, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 200 Queens Rd, Charlotte, NC 28204 Phone: 434-982-0777 Fax: 434-982-0792 | |
Mr. Andrew Joseph Bojanowski, PA-C Radiology Medicare: Accepting Medicare Assignments Practice Location: 3623 Latrobe Dr Ste 216, Charlotte, NC 28211 Phone: 704-332-1291 | |
Dr. John William Black, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3623 Latrobe Dr, Suite 216, Charlotte, NC 28211 Phone: 704-332-1291 Fax: 704-332-5206 |